217 related articles for article (PubMed ID: 36403055)
41. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N
Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295
[TBL] [Abstract][Full Text] [Related]
42. Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone.
Lu X; Kang Y
J Biol Chem; 2009 Oct; 284(42):29087-96. PubMed ID: 19720836
[TBL] [Abstract][Full Text] [Related]
43. CCR2-positive monocytes recruited to inflamed lungs downregulate local CCL2 chemokine levels.
Maus UA; Wellmann S; Hampl C; Kuziel WA; Srivastava M; Mack M; Everhart MB; Blackwell TS; Christman JW; Schlöndorff D; Bohle RM; Seeger W; Lohmeyer J
Am J Physiol Lung Cell Mol Physiol; 2005 Feb; 288(2):L350-8. PubMed ID: 15516494
[TBL] [Abstract][Full Text] [Related]
44. Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.
Maxwell PJ; Neisen J; Messenger J; Waugh DJ
Oncotarget; 2014 Jul; 5(13):4895-908. PubMed ID: 24970800
[TBL] [Abstract][Full Text] [Related]
45. Spiral ligament fibrocyte-derived MCP-1/CCL2 contributes to inner ear inflammation secondary to nontypeable H. influenzae-induced otitis media.
Woo JI; Pan H; Oh S; Lim DJ; Moon SK
BMC Infect Dis; 2010 Oct; 10():314. PubMed ID: 21029462
[TBL] [Abstract][Full Text] [Related]
46. A CCL2-based fusokine as a novel biopharmaceutical for the treatment of CCR2-driven autoimmune diseases.
Rafei M; Galipeau J
Crit Rev Immunol; 2010; 30(5):449-61. PubMed ID: 21083526
[TBL] [Abstract][Full Text] [Related]
47. Insights into CC Chemokine Ligand 2/Chemokine Receptor 2 Molecular Recognition: A Step Forward toward Antichemotactic Agents.
David KS; Oliveira ERA; Horta BAC; Valente AP; de Paula VS
Biochemistry; 2017 Jun; 56(25):3197-3210. PubMed ID: 28570817
[TBL] [Abstract][Full Text] [Related]
48. Monocyte-Induced Prostate Cancer Cell Invasion is Mediated by Chemokine ligand 2 and Nuclear Factor-κB Activity.
Lindholm PF; Sivapurapu N; Jovanovic B; Kajdacsy-Balla A
J Clin Cell Immunol; 2015 Apr; 6(2):. PubMed ID: 26317041
[TBL] [Abstract][Full Text] [Related]
49. Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis.
Zhang C; Yang Q
Front Oncol; 2020; 10():572203. PubMed ID: 33634012
[TBL] [Abstract][Full Text] [Related]
50. CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway.
Yasui H; Kajiyama H; Tamauchi S; Suzuki S; Peng Y; Yoshikawa N; Sugiyama M; Nakamura K; Kikkawa F
Clin Exp Metastasis; 2020 Feb; 37(1):145-158. PubMed ID: 31541326
[TBL] [Abstract][Full Text] [Related]
51. Serum chemokine (CC motif) ligand 2 level as a diagnostic, predictive, and prognostic biomarker for prostate cancer.
Izumi K; Mizokami A; Lin HP; Ho HM; Iwamoto H; Maolake A; Natsagdorj A; Kitagawa Y; Kadono Y; Miyamoto H; Huang CK; Namiki M; Lin WJ
Oncotarget; 2016 Feb; 7(7):8389-98. PubMed ID: 26701731
[TBL] [Abstract][Full Text] [Related]
52. Lung-specific overexpression of CC chemokine ligand (CCL) 2 enhances the host defense to Streptococcus pneumoniae infection in mice: role of the CCL2-CCR2 axis.
Winter C; Taut K; Srivastava M; Länger F; Mack M; Briles DE; Paton JC; Maus R; Welte T; Gunn MD; Maus UA
J Immunol; 2007 May; 178(9):5828-38. PubMed ID: 17442967
[TBL] [Abstract][Full Text] [Related]
53. Usefulness of serum CCL2 as prognostic biomarker in prostate cancer: a long-term follow-up study.
Iwamoto H; Izumi K; Nakagawa R; Toriumi R; Aoyama S; Shimada T; Kano H; Makino T; Kadomoto S; Yaegashi H; Kawaguchi S; Nohara T; Shigehara K; Kadono Y; Mizokami A
Jpn J Clin Oncol; 2022 Nov; 52(11):1337-1344. PubMed ID: 35726158
[TBL] [Abstract][Full Text] [Related]
54. Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer.
Li D; Ji H; Niu X; Yin L; Wang Y; Gu Y; Wang J; Zhou X; Zhang H; Zhang Q
Cancer Sci; 2020 Jan; 111(1):47-58. PubMed ID: 31710162
[TBL] [Abstract][Full Text] [Related]
55. Role of monocyte chemotactic protein-1/CC chemokine ligand 2 on gamma delta T lymphocyte trafficking during inflammation induced by lipopolysaccharide or Mycobacterium bovis bacille Calmette-Guérin.
Penido C; Vieira-de-Abreu A; Bozza MT; Castro-Faria-Neto HC; Bozza PT
J Immunol; 2003 Dec; 171(12):6788-94. PubMed ID: 14662884
[TBL] [Abstract][Full Text] [Related]
56. Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers.
Do HTT; Lee CH; Cho J
Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31991604
[TBL] [Abstract][Full Text] [Related]
57. [Relationship between the expression of chemokines and their receptors in the maternal-fetal interface and pathogenesis of unexplained recurrent spontaneous abortion].
Zhang Y; Wang J; Gu Y; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Aug; 50(8):608-13. PubMed ID: 26675185
[TBL] [Abstract][Full Text] [Related]
58. Prognostic significance of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in diffuse large B cell lymphoma.
Li YL; Shi ZH; Wang X; Gu KS; Zhai ZM
Ann Hematol; 2019 Feb; 98(2):413-422. PubMed ID: 30374624
[TBL] [Abstract][Full Text] [Related]
59. The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity.
Monti P; Leone BE; Marchesi F; Balzano G; Zerbi A; Scaltrini F; Pasquali C; Calori G; Pessi F; Sperti C; Di Carlo V; Allavena P; Piemonti L
Cancer Res; 2003 Nov; 63(21):7451-61. PubMed ID: 14612545
[TBL] [Abstract][Full Text] [Related]
60. Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension.
Sanchez O; Marcos E; Perros F; Fadel E; Tu L; Humbert M; Dartevelle P; Simonneau G; Adnot S; Eddahibi S
Am J Respir Crit Care Med; 2007 Nov; 176(10):1041-7. PubMed ID: 17823354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
